Moneycontrol PRO
HomeNewsBusinessMarketsCastrol India, Gland Pharma not eligible to enter F&O, NSE modifies previous order

Castrol India, Gland Pharma not eligible to enter F&O, NSE modifies previous order

A circular modifying the previous intimation, dated January 7, was shared by NSE, citing incomplete 'eligibility criteria' as the reason behind the decision to exclude.

January 24, 2025 / 13:09 IST
There is no change for other four securities, namely, NBCC, Phoenix, Solar Industries India and Torrent Power, as mentioned in the circular earlier.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The National Stock Exchange (NSE) will be excluding shares of Castrol India and Gland Pharma from the Futures & Options (F&O) segment starting January 31, a statement from the exchange said on January 24.

    A circular modifying the previous intimation, dated January 7, was shared by NSE, citing incomplete 'eligibility criteria' as the reason behind the decision to exclude. "...it is being hereby informed that the below securities have not fulfilled one of the eligibility criteria as
    on date," said NSE, naming Castrol India and Gland Pharma in its latest communication.

    "Members are requested to note that the availability of the above two securities for trading in Futures & Options contracts with effect from January 31, 2025 stands withdrawn," the circular said. No further explanation has been shared as to what criteria was not fulfilled, leading to the withdrawal from the segment.

    Previously, NSE had proposed to include six companies, including these two, in the F&O space for trading from January 31, 2025. There is no change for other four securities, namely, NBCC, Phoenix, Solar Industries India and Torrent Power, as mentioned in the circular earlier.

    The National Stock Exchange had also announced the removal of 16 stocks from the F&O segment, effective February 28, 2025, stating that no contracts will be available for trading beyond this date.

    The excluded stocks include PVR Inox, United Breweries, Abbott India, Atul, Bata India, Can Fin Homes, Coromandel International, City Union Bank, Gujarat Narmada Valley Fertilizers and Chemicals, Gujarat Gas, IndiaMart Intermesh, IPCA Laboratories, Dr. Lal Path Labs, Metropolis Healthcare, Navin Fluorine International, and Sun TV Network.

    The market lot and scheme of strikes of the securities shall be informed to members on January 30, 2025 through a separate circular. Analysts have previously said that inclusion in the derivatives segment can significantly enhance trading volumes and price discovery for these stocks.

    NSE's MD and CEO Ashish Chauhan has in the past said that many of these stocks were included after achieving higher liquidity and size thresholds.

    Moneycontrol News
    first published: Jan 24, 2025 01:09 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347